US Patent Issued to REGENERON PHARMACEUTICALS on June 10 for "Immunoglobulin proteins that bind to NPR1 agonists" (New York, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,752, issued on June 10, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Immunoglobulin proteins that bind to NPR1 agonists" was invented by Michael E. Dunn (Montvale, N.J.), Lori C. Morton (Chappaqua, N.Y.), Neil Stahl (Carmel, N.Y.), Tammy T. Huang (Cross River, N.Y.), Ishita Chatterjee (Nanuet, N.Y.), Vishal Kamat (Northbridge, Mass.) and Ashique Rafique (Yonkers, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides novel immunoglobulin proteins that bind to a human natriuretic peptide receptor 1 (NPR1) agonist, preferably an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosur...